Global Vitamin B1 (Thiamine) Market Size By Type (Food Grade, Feed Grade), By Application (Food Industry, Pharmaceuticals Industry), By Region, And Segment Forecasts, 2023 to 2032

The Global Vitamin B1 (Thiamine) Market was valued at USD 410 million in 2023 and is projected to reach USD 695 million by 2031, growing at a CAGR of 6.7% during the forecast period from 2023 to 2031. Thiamine, an essential water-soluble vitamin, plays a vital role in glucose metabolism and nerve, muscle, and heart function. The growing awareness regarding vitamin deficiencies, increasing health-consciousness, and rising demand for nutritional supplements are key factors driving market growth. Additionally, the expanding use of thiamine in pharmaceuticals, food & beverages, and animal nutrition is propelling its global demand.

Drivers

1. Rising Prevalence of Vitamin Deficiencies

Increasing global cases of vitamin B1 deficiency, especially among the geriatric and malnourished populations, are creating strong demand for supplementation through pharmaceuticals and functional foods.

2. Growth in Functional Food and Nutraceutical Consumption

Consumer interest in preventive healthcare and wellness is spurring the demand for vitamin-fortified products. Thiamine is widely used in energy drinks, cereals, and dietary supplements, fueling market expansion.

3. Expanding Pharmaceutical Applications

The pharmaceutical industry's growing use of vitamin B1 to treat disorders such as beriberi, Wernicke-Korsakoff syndrome, and diabetes-related complications is further supporting market growth.

Restraints

1. High Production and Formulation Costs

The extraction and formulation of high-purity thiamine involve substantial manufacturing costs, which can pose a barrier, particularly in price-sensitive markets.

2. Regulatory Challenges in Fortification Policies

Stringent global food and drug safety regulations may hinder product innovation and delay approvals for new thiamine-based formulations.

Opportunity

1. Demand Surge in Emerging Markets

Countries in Asia-Pacific and Latin America are witnessing a rise in health awareness and healthcare investments, offering lucrative opportunities for vitamin B1 manufacturers.

2. Innovation in Delivery Formats

Ongoing R&D in nanoencapsulation, sustained-release tablets, and functional beverages enriched with thiamine presents untapped potential for product diversification and market penetration.

Market by System Type Insights

By system type, Thiamine Hydrochloride emerged as the leading segment in 2023 due to its wide application in both food and pharmaceutical industries. It is preferred for its high bioavailability and stability. Meanwhile, Thiamine Mononitrate is expected to witness robust growth, particularly in functional foods and energy formulations, driven by evolving consumer preferences for fortified products.

Market by End-use Insights

In 2023, the Pharmaceuticals segment held the largest revenue share, owing to high demand for thiamine-based drugs for neurological and metabolic disorders. The Food & Beverage sector is projected to grow significantly over the forecast period, supported by increasing incorporation of thiamine in fortified products, infant formulas, and energy drinks. The Animal Feed segment is also growing steadily, especially in livestock and poultry industries.

Market by Regional Insights

Asia-Pacific dominated the global market in 2023, driven by a high prevalence of nutritional deficiencies, expanding middle-class population, and increasing adoption of fortified products in countries like China and India. North America follows closely, with strong demand from the dietary supplements and pharmaceutical sectors. Europe also holds a substantial share, bolstered by rising functional food consumption and proactive healthcare policies.

Competitive Scenario

Leading companies in the global vitamin B1 (thiamine) market include BASF SE, DSM, Huazhong Pharmaceutical Co. Ltd., Xinfa Pharmaceutical, Amway Corp., Lonza Group, Riken Vitamin Co., Ltd., and Jiangxi Tianxin Pharmaceutical Co. Ltd. These players are focused on expanding production capacity, launching novel formulations, and entering strategic collaborations to strengthen their global presence.

Scope of Work – Global Vitamin B1 (Thiamine) Market

Key Market Developments

2023: DSM launched a new line of thiamine-boosted wellness supplements targeting metabolic and cognitive health.

2024: Huazhong Pharmaceutical expanded its thiamine hydrochloride production facility in China to meet rising domestic and international demand.

2025: BASF entered into a collaboration with a European food giant to develop thiamine-enriched cereal products aimed at the preventive healthcare segment.

FAQs

1) What is the current market size of the Global Vitamin B1 (Thiamine) Market?

The market was valued at USD 410 million in 2023.

2) What is the major growth driver of the Global Vitamin B1 (Thiamine) Market?

The primary growth driver is the rising prevalence of thiamine deficiency and the expanding use of thiamine in pharmaceuticals and functional foods.

3) Which is the largest region during the forecast period in the Global Vitamin B1 (Thiamine) Market?

Asia-Pacific is projected to be the largest region due to growing health awareness and government-supported fortification initiatives.

4) Which segment accounted for the largest market share in the Global Vitamin B1 (Thiamine) Market?

The Pharmaceuticals segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Vitamin B1 (Thiamine) Market?

Key players include BASF SE, DSM, Huazhong Pharmaceutical, Xinfa Pharmaceutical, Lonza Group, and Riken Vitamin Co., Ltd.